The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

The study followed 351 patients across four Korean hospitals who had received anti-tuberculosis treatment for more than six months. These individuals were monitored over 11 years (132 months) to ...

Two international clinical studies led by PD Dr Norbert Heinrich at the Institute of Infectious Diseases and Tropical Medicine at LMU University Hospital Munich with international partners have shown ...

Good health insurance becomes the need of the hour that thwarts individuals against falling into any untoward financial trap ...

Chronic cough is a common but often misdiagnosed symptom, requiring thorough evaluation for underlying respiratory or systemic issues.

Given the severity of the issue, ASEAN's regional action plan, established in 2018, to eliminate tuberculosis by 2035, is ...

PhonePe, a digital payments platform, offers a Dengue and Malaria Insurance Plan that provides targeted health coverage ...

Lack of testing accounts for the highest number of patients lost in the TB care cascade, and stigma keeps many patients from ...

Linezolid was introduced by the World Health Organization (WHO) in 2022, as part of the BPaLM regimen, also comprising ...

Prayagraj: World Doctors' Day will be observed on Tuesday, July 1, under the theme ‘Behind the Mask, Who Heals the Healers' - a reflection on the ment.

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in ...

Two of the diseases that can have a serious impact on lung function are Tuberculosis (TB) and Pulmonary Fibrosis. While both result in respiratory symptoms and lung injury, they are radically ...